Literature DB >> 18307242

Primary percutaneous balloon pericardiotomy for malignant pericardial effusion.

Neil Swanson1, Intisar Mirza, Namal Wijesinghe, Gerard Devlin.   

Abstract

OBJECTIVES: Pericardial effusion associated with malignancy is a life-threatening complication of late-stage disease. While simple drainage is effective in relieving the symptoms, reaccumulation of effusion may cause further symptomatic episodes, often during a period when overall patient management is focused on improving the quality of remaining life. Over a 16-year period, we have adopted a strategy of managing such patients with balloon pericardiotomy as the initial preferred treatment. The results are described and compared to alternative management strategies.
METHODS: A retrospective analysis of patients who presented with symptomatic, malignant pericardial effusion, their management, procedural complication rates, and the need for further therapy for the same condition was made. Survival, reaccumulation rates, and readmissions after the index procedure were recorded and compared.
RESULTS: Forty-three patients were treated for malignant pericardial effusion. Balloon pericardiotomy was the primary treatment in 27/43 patients, simple drainage in 14/43, and surgery in 2/43. Reaccumulation rates between balloon pericardiotomy and simple aspiration (7.4% vs. 14.3%, respectively, P = 0.48) and complication rates (7.4% vs. 7.1%, respectively, P = 0.98) were not statistically different. Survival following intervention was driven by the underlying pathology and was poor, with overall median survival of 56 days.
CONCLUSIONS: Balloon pericardiotomy, as initial management of symptomatic malignant pericardial effusions, allows a definitive procedure to be performed at presentation. This can be achieved with low complication rates, similar to treatment by simple drainage. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18307242     DOI: 10.1002/ccd.21431

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  8 in total

1.  Diagnosis and management of pericardial effusion.

Authors:  Jaume Sagristà-Sauleda; Axel Sarrias Mercé; Jordi Soler-Soler
Journal:  World J Cardiol       Date:  2011-05-26

2.  Neoplastic pericardial disease: Old and current strategies for diagnosis and management.

Authors:  Chiara Lestuzzi
Journal:  World J Cardiol       Date:  2010-09-26

Review 3.  Pericardial disease: diagnosis and management.

Authors:  Masud H Khandaker; Raul E Espinosa; Rick A Nishimura; Lawrence J Sinak; Sharonne N Hayes; Rowlens M Melduni; Jae K Oh
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

4.  Percutaneous balloon pericardiotomy for the treatment of recurrent malignant pericardial effusion.

Authors:  Aniket Puri; Nitin Agarwal; S K Dwivedi; V S Narain
Journal:  Indian Heart J       Date:  2012-03-26

5.  Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis.

Authors:  Szymon Darocha; Michał Wilk; Anna Walaszkowska-Czyż; Jarosław Kępski; Rafał Mańczak; Marcin Kurzyna; Adam Torbicki; Sebastian Szmit
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

6.  Performance, pain, and quality of life on use of central venous catheter for management of pericardial effusions in patients undergoing coronary artery bypass graft surgery.

Authors:  Kamran Ghods; Mohammad Reza Razavi; Mohammad Forozeshfard
Journal:  J Pain Res       Date:  2016-10-31       Impact factor: 3.133

7.  Percutaneous Balloon Pericardiotomy (PBP) Revisited: A Case Report and Review of Literature.

Authors:  Raed Aqel; Muawiyah Elqadi; Ahmad Hammouri; Mohammad S Alqadi
Journal:  Case Rep Cardiol       Date:  2020-05-31

8.  Early and long-term outcomes of pericardiotomy in the treatment of primary cardiac tamponade.

Authors:  Bartłomiej Perek; Iga Tomaszewska; Sebastian Stefaniak; Agnieszka Bartczak; Marek Jemielity
Journal:  Kardiochir Torakochirurgia Pol       Date:  2015-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.